Wednesday, February 8, 2023
manilastandard.net
ADVERTISEMENT
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Others
    • Pets
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Technology
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • MS ON THE ROAD
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Gallery
      • Photos
      • Videos
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
  • Advertise with Us
No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Others
    • Pets
    • Pop.Life
      • Newsmakers
      • Hangouts
      • A-Pop
      • Post Its
      • Performances
      • Malls & Bazaars
      • Hobbies & Collections
    • Technology
      • Gadgets
      • Computers
      • Business
      • Tech Plus
    • MS ON THE ROAD
      • Sedan
      • SUV
      • Truck
      • Bike
      • Accessories
      • Motoring Plus
      • Commuter’s Corner
    • Home & Design
      • Residential
      • Commercial
      • Construction
      • Interior
    • Spotlight
    • Gallery
      • Photos
      • Videos
    • Events
      • Seminars
      • Exhibits
      • Community
    • Biyahero
      • Travel Features
      • Travel Reels
      • Travel Logs
  • Advertise with Us
No Result
View All Result
manilastandard.net
No Result
View All Result
Home News Coronavirus 2019

WHO ‘strongly recommends’ Pfizer’s Covid pill

AFPbyAFP
April 22, 2022, 7:21 am
in Coronavirus 2019, World News
Reading Time: 3 mins read
A A
Share on FacebookShare on TwitterShare on Email

The World Health Organization said Friday it “strongly recommended” Pfizer’s Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalisation.

However the UN agency warned it was “extremely concerned” that the inequality in access seen with Covid vaccines would again leave low- and middle-income countries “pushed to the end of the queue”.

US pharma giant Pfizer’s combination of nirmatrelvir and ritonavir was the “superior choice” of treatment for unvaccinated, elderly or immunocompromised people with Covid, the WHO’s experts said in the BMJ medical journal.

For the same patients, the WHO also made a “conditional (weak) recommendation” of the antiviral drug remdesivir made by US biotech firm Gilead — which it had previously recommended against.

The WHO recommended Paxlovid over remdesivir, as well as over Merck’s molnupiravir pill and monoclonal antibodies.

ADVERTISEMENT

Pfizer’s oral treatment prevents hospitalisation more than the “available alternatives, has fewer concerns with respects to harms than molnupiravir, and is easier to administer than intravenous remdesivir and antibodies,” the WHO’s experts said.

The new recommendation was based on the findings of two trials involving almost 3,100 patients which showed that Paxlovid reduced the risk of hospital admission by 85 percent.

The trials also “suggested no important difference in mortality” and “little or no risk of adverse effects leading to drug discontinuation”. 

The recommendation applies to people over the age of 18, but not to pregnant or breastfeeding women.

It also does not apply to patients with a low risk of complications from the disease, because the benefit would be minimal.

The WHO’s experts also declined to give an opinion for patients with severe forms of the disease, due to a lack of data.

– Limitations and inequities –

The WHO stressed the limitations of such antiviral treatments. 

“The medicine can only be administered while the disease is at its early stages,” they said.

This means the patients must quickly test positive and be prescribed the pill by a doctor — all of which can pose obstacles for low- and middle-income countries, the WHO said.

Yet Covid pills have been seen as a potentially huge step in ending the pandemic as they can be taken at home, rather than in hospital.

Patients must start taking their Paxlovid pills within five days of the onset of symptoms — the course then lasts five days.

Remdesivir can be taken within seven days of symptoms setting in, but it is administered intravenously over three days.

– Questions about cost –

The WHO called on Pfizer to “make its pricing and deals more transparent” for Paxlovid.

Lisa Hedman, the WHO’s senior advisor on access to medicines, said that radio station NPR reported a full course of Paxlovid costs $530 in the United States. Another source unconfirmed by WHO gave the price of $250 in an upper-middle income country.

Remdesivir meanwhile costs $520, Hedman said, but generic versions made by companies in India sell for $53-$64. 

There is also a question mark over whether the virus could build resistance to these treatments.

But earlier this month Pfizer CEO Albert Bourla predicted a bright future for treatments like Paxlovid as people grow tired of getting further booster vaccinations.

Coming under fire for prioritising wealthy countries with its vaccine, Pfizer has agreed to allow some generic drugmakers around the world to make cheaper versions of Paxlovid under a UN-backed scheme. 

But on Friday the WHO “strongly recommended” that Pfizer let more generic manufacturers produce the drug and “make it available faster at affordable prices”.

Tags: corona virusPfizerWHO
ADVERTISEMENT
AFP

AFP

Related Posts

UN chief fears world headed for ‘wider war’ over Ukraine

byAngelica Villanueva
February 7, 2023, 6:40 pm
0
8
UN chief fears world headed for ‘wider war’ over Ukraine

United Nations chief Antonio Guterres warned nations Monday that he fears the likelihood of further escalation in the Russia-Ukraine conflict...

Read more

Optimistic Biden to try to lift US via State of Union speech

byAFP
February 7, 2023, 6:30 pm
0
8
Junta to jail Suu Kyi for 3 years for poll fraud

Washington—An optimistic President Joe Biden will seek to lift an often-unenthusiastic nation Tuesday with a State of the Union address...

Read more

N. Korea pledges military ‘expanded, intensified’ drills

byAFP
February 7, 2023, 6:20 pm
0
8
Nokor says it tested ‘tactical nuke’ cruise missiles

Seoul—North Korea’s top army officials have said they will expand and intensify military drills to ensure their readiness for war,...

Read more

UNDP study: Jobs, not doctrine, lure for Africa’s jihadists

byAFP
February 7, 2023, 6:10 pm
0
8
Southwoods nails Seniors’ Fil golf crown

Geneva—Poverty and the prospect of better-paid work, rather than ideology, are what fuel recruitment to jihadist and other violent groups...

Read more

Pakistan lifts ‘blasphemy’ ban on Wikipedia

byAFP
February 7, 2023, 6:00 pm
0
8
Southwoods nails Seniors’ Fil golf crown

Islamabad—Wikipedia was back online in Pakistan on Tuesday, after the country’s prime minister ordered authorities to lift a block imposed...

Read more

Disney+ in Hong Kong drops ‘Simpsons’ episode with ‘forced labour’ mention

byAFP
February 7, 2023, 1:00 pm
0
8
Disney+ in Hong Kong drops ‘Simpsons’ episode with ‘forced labour’ mention

An episode of "The Simpsons" that refers to "forced labour camps" in China is nowhere to be found on the...

Read more

Print Edition

View More

Recent Posts

  • Sneakers for Makati : AB4.0
  • PH mission off to Turkey, Syria
  • It could happen here, too—Phivolcs
  • WHO warns up to 23m people could be affected by 7.8 tremor
  • Speaker slams agri traders to ‘moderate greed’
  • Jan. inflation hit 14-year high 8.7% as prices of basic needs soar
  • Labor group: Rising prices erode daily wage by P88
  • Omicron strain XBB1.5 here

Advertisement

Latest News

Jan. inflation hit 14-year high 8.7% as prices of basic needs soar

byJulito G. Radaand4 others
February 8, 2023, 1:00 am
0
8
ADB cuts ‘developing Asia’ growth forecast as China lockdowns bite

Inflation rose to its highest level in more than 14 years and showed no sign of easing in January, rising...

Read more

Labor group: Rising prices erode daily wage by P88

byVito Barcelo
February 8, 2023, 12:50 am
0
8
Wages up in Calabarzon, Davao

At least P88 has been eroded from the P570 minimum wage in Metro Manila due to the continuous rise in...

Read more

Omicron strain XBB1.5 here

byWillie Casas
February 8, 2023, 12:40 am
0
8
PH logs 2 Omicron cases

The Philippines has confirmed its first case of the coronavirus omicron subvariant XBB.1.5, which experts said causes the most transmissible...

Read more

PBBM to Pinoys: Pay correct taxes

byVince Lopez
February 8, 2023, 12:30 am
0
8
PBBM to Pinoys: Pay correct taxes

President Ferdinand Marcos Jr. on Tuesday encouraged Filipinos to pay the correct taxes critical to the government and moving the...

Read more

Palace reveals new appointees for OP, LWUA

byVince Lopez
February 8, 2023, 12:20 am
0
8
Vax wastage, infection surge feared in Odette-hit areas

Malacañang on Tuesday released the latest appointments in two departments under the administration of President Ferdinand R. Marcos Jr. Among...

Read more

Advertisement

ADVERTISEMENT
Facebook Twitter Instagram Youtube

ABOUT US

Manila Standard

Manila Standard website (manilastandard.net), launched in August 2002, extends the newspaper’s reach beyond its traditional readers and makes its brand of Philippine news and opinion available to a much wider and geographically diverse readership here and overseas.

Digital Edition

In tone and content, the online edition mirrors the editorial thrust of the newspaper. While hewing to the traditional precepts of fairness and objectivity, MS believes the news of the day need not be staid, overly long or dry. Stories are succinct, readable and written in a lively style that has become a hallmark of the newspaper.

Download – Today’s Paper

Search

No Result
View All Result

6th Floor Universal Re Bldg., 106 Paseo De Roxas cor. Perea Street, Legaspi Village, 1226 Makati City Philippines

Trunklines: 832-5554, 832-5556, 832-5558

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

No Result
View All Result
  • About
  • News
    • Top Stories
    • National
    • World News
    • Pinoy Abroad
    • Features
  • Opinion
    • Editorial
    • Columns
    • Soundbytes
  • LGUs
    • NCR
    • Luzon
    • Visayas
    • Mindanao
  • Business
    • Corporate
    • Economy & Trade
    • Stocks
    • Money
    • Agri & Mining
    • Power & Tech
    • IT & Telecom
  • Sports
    • Basketball
    • Volleyball
    • Fightsports
    • Active
    • Sports Plus
    • One Championship
    • Columns
  • Entertainment
    • TV & Movies
    • Celebrity Profiles
    • Music & Concerts
    • Digital Media
    • Columns
  • Lifestyle
    • Food
    • Culture & Media
    • Fashion
    • Health and Home
    • Leisure
    • Shopping
    • Columns
  • Pop.Life
    • Newsmakers
    • Hangouts
    • A-Pop
    • Post Its
    • Performances
    • Malls & Bazaars
    • Hobbies & Collections
  • Technology
    • Gadgets
    • Computers
    • Business
    • Tech Plus
  • MS ON THE ROAD
    • Sedan
    • SUV
    • Truck
    • Bike
    • Accessories
    • Motoring Plus
    • Commuter’s Corner
  • Home & Design
    • Residential
    • Commercial
    • Construction
    • Interior
  • Spotlight
  • Gallery
    • Photos
    • Videos
  • Events
    • Seminars
    • Exhibits
    • Community
  • Biyahero
    • Travel Features
    • Travel Reels
    • Travel Logs
  • Pets
  • Advertise with Us

© 2021 Manila Standard - Designed and Developed by Neitiviti Studios.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Install Manila Standard Web App

Install App